1921
Volume 85, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Tanzania implemented artemether-lumefantrine (AL) as the first-line treatment for uncomplicated malaria in November of 2006 because of resistance to sulfadoxine-pyrimethamine. AL remains highly efficacious, but widespread use may soon facilitate emergence of artemisinin tolerance/resistance, which initially may be detected at the molecular level as temporal changes in the frequency of single nucleotide polymorphisms (SNPs) in the gene associated with AL resistance. In Tanzania, 830 -positive samples collected between 2003 and 2010 were examined for SNPs of at codons 86, 184, and 1246. Both the N86 and 184F increased from 2006 to 2010 (logistic regression; N86: odds ratio [95% confidence interval] = 1.35 [1.07–1.71], = 0.01; 184F: odds ratio = 1.42 [1.07–1.88], = 0.02), and no change was found for D1246 (odds ratio = 1.01 [0.80–1.28], = 0.9). The observed changes may be because of introduction of AL, and if so, this finding gives cause for concern and argues for continued surveillance of these molecular markers.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2011.11-0071
2011-12-01
2017-11-17
Loading full text...

Full text loading...

/deliver/fulltext/14761645/85/6/979.html?itemId=/content/journals/10.4269/ajtmh.2011.11-0071&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2009 World Malaria Report 2009. Available at: http://www.who.int/malaria/world_malaria_report_2009/en/index.html. Accessed May 10, 2010.
  2. Wernsdorfer WH, , 1994. Epidemiology of drug resistance in malaria. Acta Trop 56: 143156.[Crossref]
  3. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, , 2002. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2: 209218.[Crossref]
  4. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ, , 2007. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J 6: 121.[Crossref]
  5. Khalil IF, Alifrangis M, Tarimo DS, Staalso T, Satti GM, Theander TG, Ronn AM, Bygbjerg IC, , 2005. The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities. Ann Trop Med Parasitol 99: 441448.[Crossref]
  6. Duraisingh MT, Cowman AF, , 2005. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 94: 181190.[Crossref]
  7. Humphreys GS, Merinopoulos I, Ahmed J, Whitty CJ, Mutabingwa TK, Sutherland CJ, Hallett RL, , 2007. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother 51: 991997.[Crossref]
  8. Holmgren G, Hamrin J, Svard J, Martensson A, Gil JP, Bjorkman A, , 2007. Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infect Genet Evol 7: 562569.[Crossref]
  9. Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Bjorkman A, Gil JP, , 2005. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis 191: 10141017.[Crossref]
  10. Sisowath C, Ferreira PE, Bustamante LY, Dahlstrom S, Martensson A, Bjorkman A, Krishna S, Gil JP, , 2007. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health 12: 736742.[Crossref]
  11. Nkhoma S, Nair S, Mukaka M, Molyneux ME, Ward SA, Anderson TJ, , 2009. Parasites bearing a single copy of the multi-drug resistance gene (pfmdr-1) with wild-type SNPs predominate amongst Plasmodium falciparum isolates from Malawi. Acta Trop 111: 7881.[Crossref]
  12. Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le BJ, Ringwald P, Ariey F, , 2009. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J 8: 11.[Crossref]
  13. Alker AP, Lim P, Sem R, Shah NK, Yi P, Bouth DM, Tsuyuoka R, Maguire JD, Fandeur T, Ariey F, Wongsrichanalai C, Meshnick SR, , 2007. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg 76: 641647.
  14. Lekana-Douki JB, Dinzouna Boutamba SD, Zatra R, Zang Edou SE, Ekomy H, Bisvigou U, Toure-Ndouo FS, , 2011. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine. Infect Genet Evol 11: 512517.[Crossref]
  15. Clarke VD, , 1979. Chloroquine-resistant malaria acquired in Kenya and Tanzania–Denmark, Georgia, New York. Cent Afr J Med 25: 3940.
  16. Naidoo I, Roper C, , 2010. Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum . Trends Parasitol 26: 447456.[Crossref]
  17. Mmbando BP, Vestergaard LS, Kitua AY, Lemnge MM, Theander TG, Lusingu JP, , 2010. A progressive declining in the burden of malaria in north-eastern Tanzania. Malar J 9: 216.[Crossref]
  18. Lusingu JP, Jensen AT, Vestergaard LS, Minja DT, Dalgaard MB, Gesase S, Mmbando BP, Kitua AY, Lemnge MM, Cavanagh D, Hviid L, Theander TG, , 2006. Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes. Infect Immun 74: 28672875.[Crossref]
  19. Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C, , 2003. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother 47: 13471354.[Crossref]
  20. Wooden J, Kyes S, Sibley CH, , 1993. PCR and strain identification in Plasmodium falciparum . Parasitol Today 9: 303305.[Crossref]
  21. Duraisingh MT, Roper C, Walliker D, Warhurst DC, , 2000. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum . Mol Microbiol 36: 955961.[Crossref]
  22. Dlamini SV, Beshir K, Sutherland CJ, , 2010. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates. Malar J 9: 68.[Crossref]
  23. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, , 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455467.[Crossref]
  24. Payne D, , 1987. Spread of chloroquine resistance in Plasmodium falciparum . Parasitol Today 3: 241246.[Crossref]
  25. Duraisingh MT, Drakeley CJ, Muller O, Bailey R, Snounou G, Targett GA, Greenwood BM, Warhurst DC, , 1997. Evidence for selection for the tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114: 205211.[Crossref]
  26. Sisowath C, Petersen I, Veiga MI, Martensson A, Premji Z, Bjorkman A, Fidock DA, Gil JP, , 2009. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J Infect Dis 199: 750757.[Crossref]
  27. Mungthin M, Suwandittakul N, Chaijaroenkul W, Rungsrihirunrat K, Harnyuttanakorn P, Seugorn A, Na BK, , 2010. The patterns of mutation and amplification of Plasmodium falciparum pfcrt and pfmdr1 genes in Thailand during the year 1988 to 2003. Parasitol Res 107: 539545.[Crossref]
  28. Schneider AG, Premji Z, Felger I, Smith T, Abdulla S, Beck HP, Mshinda H, , 2002. A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by Chloroquine treatment in Tanzania. Infect Genet Evol 1: 183189.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.11-0071
Loading
/content/journals/10.4269/ajtmh.2011.11-0071
Loading

Data & Media loading...

  • Received : 02 Feb 2011
  • Accepted : 17 Aug 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error